BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akasov RA, Khaydukov EV. Mucosal-Associated Invariant T Cells as a Possible Target to Suppress Secondary Infections at COVID-19. Front Immunol. 2020;11:1896. [PMID: 32849648 DOI: 10.3389/fimmu.2020.01896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Akasov RA, Khaydukov EV, Andreyuk DS, Sholina NV, Sheremeta AN, Romanov DV, Kostyuk GP, Panchenko VY, Kovalchuk MV. Riboflavin for COVID-19 Adjuvant Treatment in Patients With Mental Health Disorders: Observational Study. Front Pharmacol 2022;13:755745. [DOI: 10.3389/fphar.2022.755745] [Reference Citation Analysis]
2 Choudhary S, Sharma K, Silakari O. The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options. Microb Pathog 2021;150:104673. [PMID: 33278517 DOI: 10.1016/j.micpath.2020.104673] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
3 Alberca GGF, Solis-Castro RL, Solis-Castro ME, Alberca RW. Coronavirus disease–2019 and the intestinal tract: An overview. World J Gastroenterol 2021; 27(13): 1255-1266 [PMID: 33833480 DOI: 10.3748/wjg.v27.i13.1255] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
4 Shi J, Zhou J, Zhang X, Hu W, Zhao JF, Wang S, Wang FS, Zhang JY. Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19. Front Immunol 2021;12:700152. [PMID: 34394094 DOI: 10.3389/fimmu.2021.700152] [Reference Citation Analysis]